Evidence map›Paper›PMID 33806671›Full record

ArticleNanomaterials (Basel, Switzerland)2021

SiO

Marcelo Assis, Luiz Gustavo P Simoes, Guilherme C Tremiliosi, Dyovani Coelho, Daniel T Minozzi, Renato I Santos, Daiane C B Vilela, Jeziel Rodrigues do Santos, Lara Kelly Ribeiro, Ieda Lucia Viana Rosa and 3 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Defect-Tailored AgACS omega · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marcelo AssisCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.ORCID 0000-0003-0355-5565
Luiz Gustavo P SimoesNanox Tecnologia S/A, 13562-400 São Carlos, SP, Brazil.
Guilherme C TremiliosiNanox Tecnologia S/A, 13562-400 São Carlos, SP, Brazil.
Dyovani CoelhoCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.ORCID 0000-0002-1652-7144
Daniel T MinozziNanox Tecnologia S/A, 13562-400 São Carlos, SP, Brazil.ORCID 0000-0002-6071-3606
Renato I SantosNanox Tecnologia S/A, 13562-400 São Carlos, SP, Brazil.
Daiane C B VilelaNanox Tecnologia S/A, 13562-400 São Carlos, SP, Brazil.
Jeziel Rodrigues do SantosCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.ORCID 0000-0002-3147-4757
Lara Kelly RibeiroCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.
Ieda Lucia Viana RosaCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.
Lucia Helena MascaroCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.
Juan AndrésDepartment of Physical and Analytical Chemistry, University Jaume I (UJI), 12071 Castellon, Spain.
Elson LongoCDMF, LIEC, Federal University of São Carlos-(UFSCar), 13565-905 São Carlos, SP, Brazil.

Funding

Conselho Nacional de Desenvolvimento Cientifico e Tecnológico finance code 166281/2017-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior finance code 001Financiadora de Estudos e Projetos finance code 03/2013 Ref. 0555/13Fundação de Amparo à Pesquisa do Estado de São Paulo FAPESP CEPID-finance code 2013/07296-2, FAPESP/SHELL- finance code 2017/11986-5 487 and PIPE-finance codes 15/50113-3 and 11/51084-4Ministerio de Ciencia, Innovación y Universidades project PGC2018094417-B-I00Universitat Jaume I project UJI-B2019-30
6 · The paper itself

Abstract

COVID-19, as the cause of a global pandemic, has resulted in lockdowns all over the world since early 2020. Both theoretical and experimental efforts are being made to find an effective treatment to suppress the virus, constituting the forefront of current global safety concerns and a significant burden on global economies. The development of innovative materials able to prevent the transmission, spread, and entry of COVID-19 pathogens into the human body is currently in the spotlight. The synthesis of these materials is, therefore, gaining momentum, as methods providing nontoxic and environmentally friendly procedures are in high demand. Here, a highly virucidal material constructed from SiO

Indexed as

antiviral surfacesCOVID-19ethyl vinyl acetateSiO2-Ag compositesurface plasmon resonance effectvirus elimination

Identifiers

PMID33806671
PMCPMC8001031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.